Inland American offers shareholders a way to cash out, but place limits on the buyback and values shares at no more than $6.50 a share.
Fidelity Institutional Wealth Services wants to help them make a concerted push into plan advising
Verdict may increase pressure on colleague to cooperate in investigation of founder Steven A. Cohen.
New offering grabs $2.8 billion in first few days; a JPMorgan fund has similar outflow.
<i>Breakfast with Benjamin:</i> Backing off the big bounce. Plus: Bill Gross confesses, Bank of America pays for cheesy marketing tactics, investing in wind energy and an urgent reminder to change those passwords
<i>Breakfast with Benjamin:</i> The latest IPO candidate has filed, and its numbers are 'insane.' Plus: Currency traders on their way to extinction, hedge fund managers boost gold bets (mostly), small cap strategies rule, two powerful women on Wall St. could be out of work and an Olympic update.
<i>Breakfast with Benjamin:</i> One IPO hoping investors have a short memory. Plus: Bracing for weaker earnings, here comes Fed meeting minutes, bond market opportunities, shoving investors toward behavioral finance and refusing LinkedIn requests.
<i>Breakfast with Benjamin:</i> An old manufacturer goes high tech and why its earnings still matter. Plus: Emerging-markets stocks bounce as the dollar slides; the stock market's frayed nerves; and a little corporate board turnover can go a long way toward stock performance.
<i>Breakfast with Benjamin:</i> Bank ETFs ride the choppy waves of Yellen-speak. Plus: Still waiting for Treasury yields to spike, new love for intermediate-term bond funds, hot stocks ahead of earnings reports, and even gold bugs are starting to worry about the precious metal's decline
<i>Breakfast with Benjamin:</i> At some point in the first quarter, investors got defensive. So what does that mean now? Plus: It's all about Friday's jobs report, Michael Lewis calls out the stock market for being rigged, Obamacare investing risks and opportunities, and will Janet Yellen spook the market again?
<i>Friday's menu:</i> Where investors go when BRICs crack. Plus: How advisers can &mdash; and should &mdash; deal with male and female clients, mounting sanctions drive Russia toward China for economic help, investor class-action lawsuits spike, and saving money on travel.
Markets move quickly and can take us on a roller-coaster ride; the key is to keep emotions in check.
Advisers are ratcheting up their scrutiny of Pimco in the wake of a critical report from Morningstar. While few are pulling assets from the bond fund giant, the possibility is rising. <i>(One big fund shop, however, has <a href="http://www.investmentnews.com/article/20140320/FREE/140329987" target="_blank">replaced Pimco</a> as manager of a large fund.)</i>
<i>Breakfast with Benjamin:</i> Markets wake up to China's economic slowdown. Plus: Soros deters British EU exit, an all-ETF retirement portfolio, rethinking cash-rich tech companies, undervalued Wall Street banks, and test your investor profile (for fun).
Money is flooding into exchange-traded funds focused on health care at the fastest rate in at least six years, driven by booming biotechnology and pharmaceutical sectors bringing new products to market.
Industrials to consumer spending to drug research look good. Here's why.
ETF firm launches five funds to offer pure-play exposure to Japanese companies.
Acquisition could put the fund tracker in the lead of the portfolio accounting and reporting business.
Aside from competition, it's a sign that liquid alternative investments are here to stay
After a rip-roaring 2013 and an early chill in 2014, stocks are either on the cusp of a correction or poised for further gains. Bonds, meanwhile, still face rising rates at some point, with tapering in full swing. What's an investor to do?
